Update on the Drug Development Pipeline for Myeloma

In this video, Dr. James Berenson discusses the 10-year myeloma survival data presented at ASH 2011 and covers a large number of drugs that are nearing an FDA decision as well as treatments that are further upstream. For patients interested in the science of how these drugs work, Dr. Berenson shares his insight and his excitement about this point in time for myeloma treatment
Health Topics: Multiple Myeloma
Get Email Updates:
Get updated automatically when new content about Multiple Myeloma has been posted.
Privacy Policy
Privacy Policy
Multiple Myeloma
Experts & Guests
|
James Berenson, M.D.
Founder, President and Medical and Scientific Director, Institute for Myeloma and Bone Cancer Research
James Berenson, M.D. is the Founder, President & Chief Executive Officer of the Institute for Myeloma and Bone Cancer Research. Dr. Berenson has specialized in research related to myeloma and metastatic bone disease both in the basic and clinical areas for more than 25 years. He has been involved in many of the major breakthroughs that have brought new treatments for...
more >
|
|
|

























































